RYAN KING: Open Payments
NPI 1023753407 · GOLDSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 14 payments from 8 companies in 2025. Trend: 2023 $169 · 2024 $467 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $64 |
| Amgen Inc. | 3 | $43 |
| Lilly USA, LLC | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| ABBVIE INC. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Abbott Laboratories | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: Ozempic, ZEPBOUND, OTEZLA, VRAYLAR, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, Rybelsus, GARDASIL 9.
Industry payments across NC — which companies pay providers there.
